Day One Biopharmaceuticals, INC. (DAWN) — DEF 14A Filings
All DEF 14A filings from Day One Biopharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Day One Biopharma Files Definitive Proxy Statement
— Apr 11, 2025 Risk: low
Day One Biopharmaceuticals, Inc. filed a definitive proxy statement (DEF 14A) on April 11, 2025, for its annual meeting of stockholders on June 2, 2025. The fil -
Day One Biopharma Files Proxy Statement for May Meeting
— Apr 5, 2024 Risk: low
Day One Biopharmaceuticals, Inc. filed a definitive proxy statement (DEF 14A) on April 5, 2024, for its annual meeting on May 23, 2024. The company, incorporate
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX